All lobbying filings

BAXTER HEALTHCARE CORPORATION

Lobbying for BAXTER HEALTHCARE CORPORATION

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $360,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 5

Medicare/Medicaid

Issues related to pharmaceutical pricing. Issues related to drug shortages. Issues related to implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act.

Health Issues

Issues relating to drug pricing, 340B Drug pricing, device sterilization. Issues relating to safe mobility and issues relating to diabetic retinopathy. Issues relating to pandemic preparedness act. Issues related to artificial intelligence technology in healthcare; issues related to Hurricane Helene. Issues around emergency preparedness and critical medical supplies.

Budget/Appropriations

Issues related to increasing funding for Strategic National Stockpile. Labor, Health, and Human Services appropriations.

Taxation/Internal Revenue Code

Taxation of multinational companies. Monitor tax reform proposal relating to corporate tax policies. Issues related to implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act.

Trade (domestic/foreign)

None.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.